Search: WFRF:(Lundgren Anna 1974)
> (2010-2014) >
Development and pre...
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant
-
- Holmgren, Jan, 1944 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology
-
Bourgeois, L. (author)
-
Carlin, N. (author)
-
show more...
-
Clements, J. (author)
-
Gustafsson, B. (author)
-
- Lundgren, Anna, 1974 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology
-
- Nygren, Erik (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology
-
- Tobias, Joshua, 1969 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology
-
Walker, R. (author)
-
- Svennerholm, Ann-Mari, 1947 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology
-
show less...
-
(creator_code:org_t)
- Elsevier BV, 2013
- 2013
- English.
-
In: Vaccine. - : Elsevier BV. - 0264-410X .- 1873-2518. ; 31:20, s. 2457-2464
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://gup.ub.gu.se...
-
show less...
Abstract
Subject headings
Close
- A first-generation oral inactivated whole-cell enterotoxigenic Escherichia coli (ETEC) vaccine, comprising formalin-killed ETEC bacteria expressing different colonization factor (CF) antigens combined with cholera toxin B subunit (CTB), when tested in phase III studies did not significantly reduce overall (generally mild) ETEC diarrhea in travelers or children although it reduced more severe ETEC diarrhea in travelers by almost 80%. We have now developed a novel more immunogenic ETEC vaccine based on recombinant non-toxigenic E. coli strains engineered to express increased amounts of CF antigens, including CS6 as well as an ETEC-based B subunit protein (LCTB. A), and the optional combination with a nontoxic double-mutant heat-labile toxin (LT) molecule (dmLT) as an adjuvant.Two test vaccines were prepared under GMP: (1) A prototype E. coli CFA/I-only formalin-killed whole-cell. +. LCTB. A vaccine, and (2) A "complete" inactivated multivalent ETEC-CF (CFA/I, CS3, CS5 and CS6 antigens) whole-cell. +. LCTB. A vaccine. These vaccines, when given intragastrically alone or together with dmLT in mice, were well tolerated and induced strong intestinal-mucosal IgA antibody responses as well as serum IgG and IgA responses to each of the vaccine CF antigens as well as to LT B subunit (LTB). Both mucosal and serum responses were further enhanced (adjuvanted) when the vaccines were co-administered with dmLT. We conclude that the new multivalent oral ETEC vaccine, both alone and especially in combination with the dmLT adjuvant, shows great promise for further testing in humans.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine (hsv//eng)
Keyword
- Colonization factors
- DmLT
- ETEC
- Immune responses
- Mucosal immunity
- Vaccine
- bacterial antigen
- bacterial vaccine
- colonization factor CFA/I
- colonization factor CS3
- colonization factor CS5
- colonization factor CS6
- double mutant heat labile toxin
- enterotoxigenic Escherichia coli vaccine
- hybrid protein
- immunoglobulin A antibody
- toxin
- unclassified drug
- adjuvant therapy
- animal experiment
- animal model
- antibody blood level
- antibody response
- antibody titer
- article
- bacterial colonization
- controlled study
- drug safety
- Escherichia coli
- female
- immune response
- immunization
- immunogenicity
- immunological memory
- mouse
- nonhuman
- operon
- priority journal
- protein subunit
- Adjuvants
- Immunologic
- Administration
- Oral
- Animals
- Antibody Formation
- Antigens
- Bacterial
- Bacterial Toxins
- Cholera Toxin
- Enterotoxigenic Escherichia coli
- Enterotoxins
- Escherichia coli Infections
- Escherichia coli Proteins
- Escherichia coli Vaccines
- Fimbriae Proteins
- Immunity
- Mucosal
- Immunoglobulin A
- Immunoglobulin G
- Intestines
- Mice
- Mice
- Inbred BALB C
- Mutant Proteins
- Vaccines
- Inactivated
- ETEC
- Colonization factors
- Vaccine
- dmLT
- Immune responses
- Mucosal immunity
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
Vaccine
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Holmgren, Jan, 1 ...
-
Bourgeois, L.
-
Carlin, N.
-
Clements, J.
-
Gustafsson, B.
-
Lundgren, Anna, ...
-
show more...
-
Nygren, Erik
-
Tobias, Joshua, ...
-
Walker, R.
-
Svennerholm, Ann ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
- Articles in the publication
-
Vaccine
- By the university
-
RISE
-
University of Gothenburg